Advanced search
Publication Cover
Drug and Chemical Toxicology Volume 31, 2008 - Issue 2
Submit an article Journal homepage
120
Views
17
CrossRef citations to date
0
Altmetric
Research Article

Preclinical Safety and Pharmacology of Hematide™, a Peptidic Erythropoiesis Stimulating Agent (ESA), in Rats and Monkeys

Kathryn W. Woodburn Affymax, Inc, Palo Alto, California, USA
,
Peter J. Schatz Affymax, Inc, Palo Alto, California, USA
,
Kei-lai Fong Pennsylvania Biolab Inc., Radnor, Pennsylvania, USA
,
Susan D. Wilson Aclairo Pharmaceutical Development Group, Inc., Vienna, Virginia, USA
,
Thomas Ferrell Calvert Laboratories, Olyphant, Pennsylvania, USA
,
Charles B. Spainhour Calvert Laboratories, Olyphant, Pennsylvania, USA
&
Daniel Norton Calvert Laboratories, Olyphant, Pennsylvania, USA
 show all
Pages 229-244 | Published online: 09 Oct 2008

REFERENCES

  • Arkin C., Adcock D., Ernst D., Marlar R., Parish G., Szamosi D., Warunek D. Collection, transport, and processing of blood specimens for testing plasma-based coagulation assays; approved guideline—fourth edition. NCCLS document H21-A4 (ISBN 1-56238-521-6), 2003
  • Beguin Y. Erythropoietin and platelet production. Haematologica 1999; 84: 541–547
  • Berridge M. V., Fraser J. K., Carter J. M., Lin F-K. Effects of recombinant human erythropoietin on megakaryocytes and on platelet production in the rat. Blood 1988; 72: 970–977
  • Calcieti P., Veronese F. M. Pharmacokinetic and biodistribution properties of poly(ethyleneglycol)–protein conjugates. Adv. Drug Del. Rev. 2003; 55: 1261–1277
  • Cowgill L. D., James K. M., Levy J. K., Browne J. K., Miller A., Lobingier R. T., Egrie J. C., Dwyer E., Browne J. K., Hitz A., Lykos M. A. Darbepoetin alfa has a longer circulating half-life and greater in vivo potency than recombinant human erythropoietin. Exp. Hematol. 2003; 31: 290–299
  • Fan Q., Leuther K. L., Holmes C. P., Fong K-L., Zhang J., Velkovska S., Chen M-J., Mortensen R. B., Leu K., Green J. M., Schatz P. J., Woodburn K. W. Preclinical evaluation of Hematide, a novel erythropoiesis stimulating agent for the treatment of anemia. Exp. Hematol. 2006; 34: 1303–1311
  • http://www.fda.gov/cder/biologics/products/darbamg091701.htm, U.S. Food and Drug Administration. (2001). FDA Toxicology Review of darbepoetin alfa, BLA 99–1492, Amgen, Inc., approved September 17, 2001
  • Greaves P. Histopathology of Preclinical Toxicity Studies: Interpretation and Relevance in Drug Safety Evaluation. Elsevier Science, New York 2000, 2000
  • Greaves P., Faccini J. M. Rat Histopathology: A Glossary for Use in Toxicity and Carcinogenicity Studies2nd. Elsevier, AmsterdamThe Netherlands 1992
  • Maeda N., Kon K., Tateishi N. Rheological properties of erythrocytes in recombinant human erythropoietin-administered normal rat. Br. J. Haematol. 1989; 73: 105–111
  • Moore D. M. Hematology of nonhuman primates. Schalm's Veterinary Hematology, B. F. Feldman, J. G. Zinkl, N. C. Jain. Lippincott Williams & Wilkins, Philadelphia, PennsylvaniaUSA 2000a; 1133–1144
  • Moore D. M. Hematology of the rat (Rattus norvegicus). Schalm's Veterinary Hematology, B. F. Feldman, J. G. Zinkl, N. C. Jain. Lippincott Williams & Wilkins, Philadelphia, PennsylvaniaUSA 2000b; 1210–1224
  • Muntzel M., Hannedouche T., Lacour B., Drueke T. Effect of erythropoietin on hematocrit and blood pressure in normotensive and hypertensive rats. J. Am. Soc. Nephrol. 1992; 3: 182–187
  • Nissenson A. R., Goodnough L. T., Dubois R. W. Anemia. Not just an innocent bystander?. Arch. Intern. Med. 2003; 163: 1400–1404
  • Piron M., Loo M., Gothot A., Tassin F., Fillet G., Beguin Y. Cessation of intensive treatment with recombinant human erythropoietin is followed by secondary anemia. Blood 2001; 97: 442–448
  • R'zik S., Loo M., Beguin Y. Reticulocyte transferrin receptor (TfR) expression and contribution to soluble Tfr levels. Haematoligica 2001; 86: 244–251
  • Stead R. B., Lambert J., Wessels D., Iwashita J. S., Leuther K. K., Woodburn K. W., Schatz P. J., Okamoto D. M., Naso R., Duliege A. M. Evaluation of the safety and pharmacodynamics of Hematide, a novel erythropoietic agent, in a phase 1, double-blind, placebo-controlled, dose-escalation study in healthy volunteers. Blood 2006; 108: 1830–1834
  • Tacey R., Greway A., Smiell J., Power D., Kromminga A., Daha M., Casadevall N., Kelley M. The detection of anti-erythropoietin antibodies in human serum and plasma. Part I. Validation of the protocol for a radioimmunoprecipitation assay. J. Immunol. Meth. 2003; 283: 317–329
  • Watson A. D. J., Canfield P. J. Nutritional deficiency anemias. Schalm's Veterinary Hematology5th, B. F. Feldman, J. G. Zinkl, N. C. Jain. Lippincott Williams & Wilkins, Philadelphia, PennsylvaniaUSA 2000; 190–195
  • Weiss G., Goodnough L. T. Anemia of chronic disease. N. Engl. J. Med. 2005; 352: 1011–1023
  • Woodburn K. W., Fan Q., Winslow S., Chen M-J., Mortensen R. B., Casadevall N., Stead R. B., Schatz P. J. Hematide is immunologically distinct from erythropoietin and corrects anemia induced by antierythropoietin antibodies in a rat pure red cell aplasia model. Exp. Hematol. 2007; 35: 1202–1208
  • Wrighton N. C., Farrell F. X., Chang R., Kashyap A. K., Barbone F. P., Mulcahy L. S., Johnson D. L., Barrett R. W., Jolliffe L. K., Dower W. J. Small peptides as potent mimetics of the protein hormone erythropoietin. Science 1996; 273: 458–464

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.